The integration of 3D bioprinting and AI offers multiple benefits for cancer treatment. Personalized tumor models can help in tailoring treatment plans to the individual patient, potentially improving outcomes. AI-driven analysis of these models can provide insights into the mechanisms of cancer development and progression, leading to the identification of new therapeutic targets. Moreover, this technology can facilitate the development of precision medicine approaches, ensuring that patients receive the most effective treatments based on their unique tumor characteristics.
